It acts on pancreatic β-cells, releasing insulin, and in pancreatic α-cells, inhibiting the secretion of glucagon in a glucose-dependent manner; therefore, GLP-1 controls blood glucose with a lower risk of hypoglycemia. The gene discussed is GLP1R; the disease is Hypoglycemia.